Thyrocare Technologies Limited

NSE: THYROCARE · Healthcare

₹493.10+0.68%06 Nov 2026

Ask the data

Instant answers about Thyrocare Technologies Limited — computed from its filings, no language model

Market cap₹7,849 cr

Current price₹493.10

High / Low₹1,592 / ₹350

P/E54.4

P/B14.18

Book value₹34.8

ROE26.1%

ROCE36.8%

Debt / equity0.00

Dividend yield1.89%

EPS (TTM)₹9.06

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 8 periods

	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	402.9	433.2	494.6	588.9	526.7	571.9	687.4	829.0
EBITDA	154.2	172.5	171.2	234.9	120.0	137.4	190.4	262.0
Operating margin	38.3%	39.8%	34.6%	39.9%	22.8%	24.0%	27.7%	31.6%
Interest	0.6	1.9	0.9	2.4	2.4	4.2	3.0	2.8
Depreciation	26.2	31.9	30.3	33.9	38.7	47.0	55.3	58.6
Profit before tax	137.4	139.9	152.5	227.9	87.4	95.6	146.9	211.5
Tax	52.9	52.0	39.3	51.6	24.2	26.5	54.7	50.0
Net profit	0.0	88.4	0.0	176.1	64.5	70.8	91.5	163.1
EPS ₹	15.95	16.74	21.41	33.30	12.16	13.42	17.13	10.27
Operating cash flow	—	—	—	267.0	129.3	167.6	191.3	213.2
Capex	—	—	—	37.8	43.6	61.6	44.9	20.9
Dividend paid	—	—	—	79.3	79.3	95.3	95.3	148.4
Total assets	—	—	—	—	632.7	643.9	692.8	747.2
Equity	—	—	—	—	534.3	526.8	546.8	585.5

Quarterly performance

last 33 quarters · ₹ crore

showing latest 8 of 33 periods

	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	103.9	96.3	105.6	109.7	116.2	105.8	101.4	56.3	153.2	138.3	146.8	164.7	176.2	117.4	130.6	127.8	135.0	128.0	135.9	134.9	148.0	134.7	154.2	156.9	177.4	165.9	187.2	193.0	216.5	195.5	223.9	240.0	270.8
Operating profit	43.0	35.5	34.5	45.6	52.2	43.8	31.0	8.5	61.9	49.6	51.5	71.2	89.3	36.8	37.6	35.9	31.6	27.9	24.7	34.5	37.5	31.6	33.8	42.6	48.3	41.7	57.7	57.8	71.3	57.8	75.1	77.3	89.3
Operating margin	41.4%	36.9%	32.7%	41.6%	44.9%	41.4%	30.5%	15.0%	40.4%	35.9%	35.1%	43.3%	50.7%	31.3%	28.8%	28.1%	23.4%	21.8%	18.2%	25.6%	25.4%	23.4%	21.9%	27.2%	27.2%	25.2%	30.8%	29.9%	33.0%	29.6%	33.5%	32.2%	33.0%
Other income	2.4	3.3	1.9	2.4	2.5	0.8	2.1	1.2	5.0	2.6	3.6	10.5	15.2	1.4	2.1	1.0	1.6	2.1	3.7	1.0	2.2	2.7	3.5	3.6	2.6	4.0	4.6	4.7	3.0	5.0	4.3	4.2	3.6
Interest	0.1	0.1	0.2	0.5	0.6	0.4	0.4	0.3	0.3	0.3	-0.1	0.6	0.7	0.5	0.6	0.6	0.5	0.6	0.7	0.9	1.1	1.1	1.1	1.0	0.8	0.6	0.7	0.8	0.6	-0.1	1.5	1.4	1.6
Depreciation	6.6	6.9	7.0	7.3	8.2	7.8	8.5	7.0	7.6	7.8	7.8	7.3	8.2	8.8	9.7	8.6	9.2	10.2	10.8	9.8	10.7	13.5	13.1	11.4	13.1	17.1	13.8	11.4	11.5	21.6	14.0	12.5	13.5
Profit before tax	38.7	31.8	29.2	40.1	45.8	36.4	17.6	2.4	58.9	44.1	47.5	73.8	95.6	28.9	29.5	27.8	23.5	19.7	16.9	24.8	27.9	19.8	22.9	33.9	37.1	28.1	47.8	50.2	62.3	35.1	63.9	67.6	32.9
Tax	13.9	11.8	13.0	12.9	11.0	9.0	19.2	1.9	15.8	11.7	9.9	17.9	17.7	7.2	8.8	6.3	8.2	5.0	4.8	7.7	7.9	5.2	5.7	9.6	-10.3	9.0	25.6	12.2	14.8	7.3	15.7	17.0	18.4
Net profit	25.3	0.0	0.0	0.0	35.0	27.5	-1.6	0.2	0.0	32.4	0.0	55.6	77.7	0.0	21.2	0.0	15.4	14.7	12.6	17.2	20.3	15.3	17.8	24.2	26.7	19.1	21.7	38.9	48.0	29.0	47.1	52.2	15.9
EPS ₹	4.70	3.81	3.09	5.20	6.73	5.21	-0.30	0.04	8.15	6.13	7.14	10.51	14.70	4.05	4.04	4.11	3.80	1.89	2.36	3.26	3.84	2.78	3.54	4.52	4.99	3.58	4.17	7.35	9.05	1.82	2.99	3.23	0.96
Revenue YoY	—	—	—	—	11.9%	9.9%	-3.9%	-48.7%	31.8%	30.7%	44.8%	192.6%	15.0%	-15.1%	-11.1%	-22.4%	-23.4%	9.1%	4.1%	5.6%	9.7%	5.2%	13.5%	16.3%	19.8%	23.1%	21.3%	23.0%	22.1%	17.8%	19.7%	24.3%	25.1%
Profit YoY	—	—	—	—	38.8%	—	—	—	-100.0%	17.7%	—	24065.2%	—	-100.0%	—	-100.0%	-80.1%	—	-40.7%	—	31.8%	4.4%	41.2%	40.1%	31.1%	24.5%	22.0%	61.1%	79.9%	51.8%	117.1%	34.1%	-66.9%

Earlier results (standalone, Mar '16 – Jun '18)

₹ crore · from BSE, before the NSE XBRL filings begin

Thyrocare Technologies Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

	FY17†	FY18†
Revenue	300.1	331.8
Operating profit	115.9	139.0
Operating margin	38.6%	41.9%
Other income	9.1	23.6
Interest	—	0.4
Depreciation	11.7	12.1
Profit before tax	113.3	148.0
Tax	38.5	51.9
Net profit	74.8	96.0

Quarters

showing latest 8 of 10 periods

	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†
Revenue	64.3	68.9	78.2	70.1	82.9	82.1	81.8	77.8	90.0	89.2
Operating profit	24.8	26.8	30.2	26.7	32.2	35.9	34.0	33.8	35.4	39.2
Operating margin	38.6%	39.0%	38.6%	38.1%	38.8%	43.6%	41.5%	43.4%	39.3%	44.0%
Other income	1.8	2.2	3.4	2.3	1.2	4.8	3.1	4.1	11.6	3.0
Interest	—	—	—	—	—	0.1	0.1	0.1	0.1	0.1
Depreciation	3.3	2.7	2.9	2.9	3.1	2.7	2.9	3.1	3.3	3.2
Profit before tax	23.3	26.3	30.7	26.1	30.2	35.8	34.0	34.7	43.5	38.9
Tax	7.9	9.1	10.3	9.2	9.9	12.6	10.5	12.9	15.9	13.6
Net profit	15.4	17.2	20.4	16.9	20.3	23.2	23.4	21.8	27.7	25.4
EPS ₹	3.00	3.21	3.80	3.15	3.78	4.31	4.37	4.08	5.15	4.72
Revenue YoY	—	—	—	—	28.9%	19.3%	4.6%	11.1%	8.6%	8.6%
Profit YoY	—	—	—	—	31.5%	34.5%	14.9%	28.7%	36.3%	9.5%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 30 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	7.4%	10.4%	8.0%	11.2%	13.3%	13.5%	13.4%	14.7%	17.2%	18.0%	16.8%	19.5%	23.9%	25.8%	27.8%	30.1%	26.1%
ROCE	—	—	—	—	—	—	—	—	—	—	—	—	—	22.7%	20.9%	16.9%	16.4%	18.2%	18.3%	18.2%	19.8%	24.1%	25.7%	27.4%	30.4%	35.8%	37.0%	36.6%	39.7%	36.8%
Net margin	6.1%	8.2%	14.3%	14.1%	16.1%	6.3%	6.9%	6.6%	14.6%	26.5%	22.0%	26.2%	17.9%	7.2%	9.9%	8.1%	11.2%	11.9%	11.8%	12.4%	13.1%	13.5%	13.4%	13.3%	14.7%	16.7%	17.4%	19.7%	20.1%	15.5%
EBITDA margin	38.2%	39.2%	40.3%	39.8%	35.7%	34.8%	33.6%	34.7%	38.9%	41.8%	41.1%	39.9%	36.2%	27.8%	25.5%	22.8%	22.2%	22.8%	23.2%	24.0%	24.5%	25.1%	25.4%	27.7%	28.4%	30.0%	30.9%	31.6%	32.1%	32.2%
Debt / equity	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.05	0.05	0.04	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	145.21	103.79	91.77	76.64	61.11	81.64	92.75	176.64	192.65	172.68	143.90	96.73	79.35	51.53	45.66	38.40	32.81	28.40	24.84	23.71	25.25	29.85	36.14	49.15	58.46	71.57	99.72	76.53	68.91	46.84
Asset turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	0.89	0.91	0.83	0.84	0.92	0.93	0.89	0.92	1.04	1.10	0.99	1.04	1.12	1.16	1.11	1.17	1.28

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	52.9	52.9	52.9	53.0	53.0	53.0	53.0	159.2	159.2
Other equity / reserves	439.7	481.4	433.3	473.8	435.2	493.8	481.2	426.3	394.3
Total equity	492.6	534.3	486.2	526.8	488.2	546.8	534.2	585.5	553.4
Borrowings	0.0	0.0	23.2	21.6	0.1	0.0	0.0	0.0	0.0
Current liabilities	65.6	77.1	68.6	90.5	94.8	121.8	122.1	109.9	111.0
Non-current liabilities	12.5	20.4	36.4	25.8	13.6	23.9	24.0	51.3	61.7
Total assets	570.7	632.7	592.7	643.9	597.1	692.8	680.2	747.2	725.1
Property, plant & equipment	144.7	157.4	156.2	168.4	156.1	148.7	152.9	205.6	222.3
Capital work-in-progress	4.9	1.6	2.8	2.5	0.6	14.2	3.0	3.1	0.9
Investments	102.3	150.7	97.2	162.4	108.5	161.5	145.9	176.6	168.3
Inventories	26.8	27.7	32.3	47.5	44.1	46.5	37.9	48.5	48.7
Receivables	89.6	85.1	55.4	43.5	47.9	73.0	75.5	73.9	89.3
Cash & equivalents	20.3	17.8	14.7	9.3	45.7	17.7	31.5	38.3	21.9

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	267.0	129.3	167.6	191.3	213.2
Cash from investing	-119.7	-39.0	-91.3	-52.5	-23.0
Cash from financing	-146.8	-86.2	-84.8	-130.4	-169.6
Capex	37.8	43.6	61.6	44.9	20.9
Free cash flow	229.2	85.7	106.0	146.4	192.4
Dividends paid	79.3	79.3	95.3	95.3	148.4

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹222.3 cr31%

CWIP

₹0.9 cr0%

Investments

₹168.3 cr23%

Inventories

₹48.7 cr7%

Receivables

₹89.3 cr12%

Cash & equivalents

₹21.9 cr3%

Other assets

₹173.6 cr24%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Thyrocare Technologies Limited	7,849	493.10	54.4	14.18	26.1%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-3.9%

6 months+4.8%

1 year-63.5%

3Y CAGR-3.5%

5Y CAGR-15.8%

10Y CAGR-2.5%

50-day avg₹530.65

200-day avg₹487.51

RSI (14)52

FAQs

What is the share price of Thyrocare Technologies Limited?

Thyrocare Technologies Limited (THYROCARE) closed at ₹493.10 on NSE on 06 Nov 2026.

What is the market cap of Thyrocare Technologies Limited?

₹7,849 crore at the latest close.

What is the P/E ratio of Thyrocare Technologies Limited?

54.4, on trailing-twelve-month earnings from its filings.

How fast is Thyrocare Technologies Limited growing?

Thyrocare Technologies Limited: revenue has compounded at 16.3% a year over three years; net profit at 36.2% a year. Latest-quarter revenue is up 25.1% year on year, profit down 66.9%.

How profitable is Thyrocare Technologies Limited?

On a trailing-twelve-month basis return on equity is 26.1%, return on capital employed 36.8%, operating margin 32.2%, net margin 15.5%.

How much debt does Thyrocare Technologies Limited have?

Thyrocare Technologies Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹22 cr (balance sheet of 2026-09-30). Operating profit covers interest 46.8 times.

Financials parsed from Thyrocare Technologies Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '18, annual from FY19, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.